CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT

CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT

The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YU, Lok Him Lawrence, LAI, Chiajen, YU, Richard Hung Chiu
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé de formule (Ia), des procédés de production de la forme cristalline du composé de formule (Ia), et des procédés thérapeutiques pour l'utilisation de la forme cristalline du composé de formule (Ia)